Navigation Links
Hormones do not guard against heart failure

The previous research evidence that HRT could reduce risk of heart attack in post menopausal women has been reversed by a recent study of 1000 women of ages 50 to 69 conducted by the University of Manchester in the United Kingdom.The aim of the study was to determine whether a combination// of oestrogen and progesterone reduced the risk of future heart attack in post menopausal women who had already sufferd a previous attack.

A daily dose of HRT or a placebo was given to these women and the frequency of a recurrent heart attack or cardiac death over that period was studied. It was reported that there was no significant difference, either in the number of women who suffered another heart attack or in the number of women who died because of a heart attack, between the two groups.

Researchers therefore concluded that HRT does not reduce the overall risk of future cardiac problems in women who have suffered a heart attack.


'"/>




Page: 1

Related medicine news :

1. Hormones Linked To Migraines
2. Low-Dose Hormones Help the Bones
3. Hormones A Predictor Of Heart Problems
4. Link Between Sex Hormones And Risk Of Breast Cancer
5. Debating The Link Between Sex Hormones And Multiple Sclerosis
6. Teenagers Using Hormones And Dietary Supplements To Good Physique
7. Researchers Purify Protein That Could Regulate Male Hormones
8. Hunger Hormones And Postoperative Obesity Surgery
9. Grumpy Women: Society Not Hormones At Fault
10. A Balancing Act: Hormones and the Skin
11. Hormones and the Skin: the Role Hormones Play as We Age
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...vide a bridge to a transplant.Heart failure is cha...cle to pump blood around the body. Till now, it ha...rsible - with the only real cure being a transplan...ce (LVAD) is a mechanical pump which is used to su...
...d that distribution of physician's sample by pharm...n nature of advertisement expenditure falling with...ection 37 of Income Tax Act. The nature of the ad... upon the nature and quality of the article in que...
...t-feed their children for less than three months m...ellectual potential. The results of intelligence t...ldren showed that those who had breast milk for le...t//as those who had been breast-fed for at least s...
...die from smoking, unless they give up now.A survey...shadow what is likely to happen on the mainland in...find that tobacco was the cause of 33% of all male... 30 to 65 age group. When male smokers only are co...
Other Medicine News:
(Date:9/4/2008)... 100 mg cohort demonstrates potent antiviral activ... profile -, CAMBRIDGE, Mass., Sept. 4 /PRNews...asdaq: IDIX ), a biopharmaceutical company engage...e treatment of human viral,and other infectious di...proof-of-concept study evaluating IDX899, a non-nu...
(Date:9/3/2008)... NANJING, China, Sept. 3 /PRNewswire-FirstCall/ ...eading manufacturer and supplier of,branded generi...,anti-cancer biotech product Endu (also known as E...f Endu Phase IV clinical study., At the request o...study,to further validate the safety and therapeut...
(Date:9/3/2008)... GAITHERSBURG, Md., Sept. 3 /- Pana...ance of U.S. Patent Number 7,413,737 covering,anti...ydroxylase (HAAH), a,proprietary human cancer biom...e developed in collaboration with the Massachusett...clusive, worldwide rights to this patent,for devel...
(Date:9/3/2008)... SB-509 to be Evaluated in Repeat-Dosing Study ...- Sangamo,BioSciences, Inc....ed a Phase,2 clinical trial (SB-509-801) to evalua...essive, degenerative motor-neuron disease for whic..., Sangamo,s drug, SB-509, is an injectable formul...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Medifast Inc to Announce Fourth Quarter and Fiscal Year End Results on Wednesday March 12 2008 13585 1Medifast Inc to Announce Fourth Quarter and Fiscal Year End Results on Wednesday March 12 2008 13585 2Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms 13583 1Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms 13583 2Authorities fail to recognize emotionally scarred brothers and sisters of child abuse victims 13579 1Authorities fail to recognize emotionally scarred brothers and sisters of child abuse victims 13579 2New technique takes a big step in examination of small structures 13577 1New technique takes a big step in examination of small structures 13577 2New technique takes a big step in examination of small structures 13577 3New technique takes a big step in examination of small structures 13577 4
...DALE, Fla.--(BUSINESS WIRE)--May 9, 2007 - Regener...unced positive,results from several studies evalua...age-related macular degeneration (wet AMD) and,dia...sented this,week at the annual meeting of the Asso...ARVO). The data reported at the meeting,from a pre...
...CO--(BUSINESS WIRE)--May 9, 2007 - Results of a Ph...NKTR-061 (inhaled,amikacin) to treat hospital acqu...sented at the American Thoracic Society (ATS),Inte...ancisco., ,WHO: Dr. Michael S. Niederman, MD,...hrop-University Hospital, Professor of, ...
Other Medicine Technology:VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 2VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 3VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 4VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting 5Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: